Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8659838 | Heart, Lung and Circulation | 2018 | 8 Pages |
Abstract
In the intermediate-risk patients, the 30-day and 12-month mortality are similar between TAVI and SAVR. Increased operator experience and improved device technology have led to a significant reduction in mortality in intermediate-risk patients undergoing TAVI.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kuljit MBBS, FRACP, PhD, Kristin PhD, Mohammed K. MD, Rohan MBBS, PhD, Abdulrahman MD, Alexander MD, Christopher MD, Marino MD,